Skip to content
Clinical Trials – home
The NetherlandsBack to the Netherlands

Clinical trials in Beugen

6 clinical trials in Beugen, The Netherlands. Every trial is listed in the EU Clinical Trials Register and updated daily.

The NetherlandsOur site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)
Beugen at a glance
6
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

6 trials in Beugen

Open in trial search
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Daratumumab
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
Countries:The NetherlandsThe Netherlands
  • Participants:65+ years
  • Substances:Capecitabine
  • Sponsor:Leids Universitair Medisch Centrum (LUMC)
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Darolutamide
  • Sponsor:Unicancer
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Venetoclax
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Carbasalate Calcium
  • Sponsor:Stichting Radboud University Medical Center
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:BOOG Study Center B.V.

Other cities in the Netherlands

The busiest research cities in the country

All 103 cities in the Netherlands

Clinical research in Beugen

What the registry says about research in the country

01 Cardiovascular Research

Innovative research focusing on genotype-guided antithrombotic treatment for patients with peripheral arterial disease, aiming to reduce adverse clinical events related to arterial thrombosis.

  • Arterial Thrombosis Prevention
  • Cardiovascular Event Reduction
  • Limb Preservation Strategies

Studies target improved outcomes in preventing major cardiovascular and limb events.

02 Hematologic Oncology

Groundbreaking research evaluating treatment strategies for multiple myeloma, comparing continuous therapy versus intermittent treatment approaches using novel drug combinations.

  • Treatment-Free Intervals
  • Disease Progression Monitoring
  • Survival Outcomes Assessment

Focus on optimizing treatment duration and effectiveness for newly diagnosed patients.

03 Breast Cancer Research

Advanced studies investigating hormone receptor-positive breast cancer treatments, examining the optimal sequencing of endocrine therapy combined with CDK4/6 inhibition.

  • Treatment Sequencing Strategies
  • Progression-Free Survival
  • Metastatic Disease Management

Evaluating first-line and second-line treatment combinations for improved patient outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.